Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 16Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 14Neoplasm Metastasis 7Brain Neoplasms 7Sarcoma 2Melanoma 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Cancer Recurrent 1SCLC, Extensive Stage 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Mesothelioma 1Extensive Stage Small Cell Lung Cancer 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Neuroendocrine 1Carcinoma, Large Cell 1Carcinoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Pemetrexed 40Cisplatin 35pembrolizumab 21Nivolumab 17Carboplatin 16Ipilimumab 13Gemcitabine 10Cyclophosphamide 9fludarabine 6durvalumab 6Bevacizumab 6Radiotherapy, Intensity-Modulated 4LMB-100 4Drug Therapy 4Dexamethasone 4tremelimumab 3tazemetostat 3spartalizumab 3olaparib 3niraparib 3atezolizumab 3anetumab ravtansine 3amatuximab 3Vinorelbine 3Paclitaxel 3Oxaliplatin 3Imatinib Mesylate 3Fluorouracil 3Cerebral Decortication 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Temozolomide × Thoracic × Clear all
NCT00629343 2025-06-05

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

Columbia University

Phase 1 Completed
27 enrolled 7 charts
Other solid neoplasmSarcomaThoracic

Mesothelioma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡